Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2.
Tieleman AA, Knoop H, van de Logt AE, Bleijenberg G, van Engelen BG, Overeem S. Tieleman AA, et al. J Neurol Neurosurg Psychiatry. 2010 Sep;81(9):963-7. doi: 10.1136/jnnp.2009.192591. J Neurol Neurosurg Psychiatry. 2010. PMID: 20798200
Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study.
van de Logt AE, Beerenhout CH, Brink HS, van de Kerkhof JJ, Wetzels JF, Hofstra JM. van de Logt AE, et al. PLoS One. 2015 Nov 12;10(11):e0142033. doi: 10.1371/journal.pone.0142033. eCollection 2015. PLoS One. 2015. PMID: 26562836 Free PMC article. Clinical Trial.
Pharmacological treatment of primary membranous nephropathy in 2016.
van de Logt AE, Hofstra JM, Wetzels JF. van de Logt AE, et al. Expert Rev Clin Pharmacol. 2016 Nov;9(11):1463-1478. doi: 10.1080/17512433.2016.1225497. Epub 2016 Sep 16. Expert Rev Clin Pharmacol. 2016. PMID: 27535699 Review.
Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.
van de Logt AE, Dahan K, Rousseau A, van der Molen R, Debiec H, Ronco P, Wetzels J. van de Logt AE, et al. Kidney Int. 2018 Apr;93(4):1016-1017. doi: 10.1016/j.kint.2017.12.019. Kidney Int. 2018. PMID: 29571438 Clinical Trial. No abstract available.
The authors reply.
van de Logt AE, Dahan K, Ronco P, Wetzels J. van de Logt AE, et al. Kidney Int. 2018 Oct;94(4):830. doi: 10.1016/j.kint.2018.06.018. Kidney Int. 2018. PMID: 30243321 No abstract available.
Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice.
Rops ALWMM, Jansen E, van der Schaaf A, Pieterse E, Rother N, Hofstra J, Dijkman HBPM, van de Logt AE, Wetzels J, van der Vlag J, van Spriel AB. Rops ALWMM, et al. Among authors: van de logt ae. Kidney Int. 2018 Jun;93(6):1356-1366. doi: 10.1016/j.kint.2018.01.005. Epub 2018 Mar 16. Kidney Int. 2018. PMID: 29551516
Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
Zaghrini C, Seitz-Polski B, Justino J, Dolla G, Payré C, Jourde-Chiche N, Van de Logt AE, Booth C, Rigby E, Lonnbro-Widgren J, Nystrom J, Mariat C, Cui Z, Wetzels JFM, Ghiggeri G, Beck LH Jr, Ronco P, Debiec H, Lambeau G. Zaghrini C, et al. Among authors: van de logt ae. Kidney Int. 2019 Mar;95(3):666-679. doi: 10.1016/j.kint.2018.10.024. Kidney Int. 2019. PMID: 30784662
The bias between different albumin assays may affect clinical decision-making.
van de Logt AE, Rijpma SR, Vink CH, Prudon-Rosmulder E, Wetzels JF, van Berkel M. van de Logt AE, et al. Kidney Int. 2019 Jun;95(6):1514-1517. doi: 10.1016/j.kint.2019.01.042. Epub 2019 Feb 27. Kidney Int. 2019. PMID: 31053386
The authors reply.
van de Logt AE, Rijpma SR, Vink CH, Prudon-Rosmulder E, Wetzels JF, van Berkel M. van de Logt AE, et al. Kidney Int. 2019 Jul;96(1):249. doi: 10.1016/j.kint.2019.04.008. Kidney Int. 2019. PMID: 31229039 No abstract available.
13 results
Jump to page
Feedback